Please assess the completion status of the following clinical trial:

Trial Title: Withdrawal of Medication in Recovered DCM

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Patient diagnosed with dilated cardiomyopathy (DCM) with an initial HFrEF \< 40 % at presentation.~2. DCM with recovered LV function to \> or = to 50% documented on 2 ECHO examinations, with the most recent ECHO examination within 1 year of enrolment.~3. Time from initial diagnosis of DCM more or equal to 24 month.~4. Last hospitalization for decompensated HF \> 1year.~Exclusion criteria:~1. Ischemic cardiomyopathy~2. Other structural pathology such as: Hypertrophic cardiomyopathy, Valvular cardiomyopathy or congenital heart disease.~3. Last hospitalization for decompensated HF \< 1year ago.~4. Previous sustained ventricle tachycardia or ventricle fibrillation (VF) arrest.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Treatment (Type: EXPERIMENTAL): Withdrawal of beta blockers and ACE inhibitors
- control (Type: PLACEBO_COMPARATOR): no withdrawal, standard of care

Based on this trial design, predict the completion outcome and termination type (if applicable).